Published in Int J Clin Oncol on February 24, 2015
Oligonucleotide aptamers: A next-generation technology for the capture and detection of circulating tumor cells. Methods (2015) 0.78
Circulating and disseminated tumor cells: diagnostic tools and therapeutic targets in motion. Oncotarget (2016) 0.75
Circulating tumor cell status monitors the treatment responses in breast cancer patients: a meta-analysis. Sci Rep (2017) 0.75
Melanoma antigen-encoding gene family member A1-6 and hTERT in the detection of circulating tumor cells following CD45(-) depletion and RNA extraction. Oncol Lett (2017) 0.75
Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the CellSearch system. Clin Cancer Res (2007) 6.59
Breast cancer as a global health concern. Cancer Epidemiol (2009) 2.71
HER2 status of circulating tumor cells in patients with metastatic breast cancer: a prospective, multicenter trial. Breast Cancer Res Treat (2010) 2.12
Circulating tumour cells in clinical practice: Methods of detection and possible characterization. Methods (2010) 1.81
Circulating tumour cell detection: a direct comparison between the CellSearch System, the AdnaTest and CK-19/mammaglobin RT-PCR in patients with metastatic breast cancer. Br J Cancer (2009) 1.55
Detecting circulating tumor cells: current challenges and new trends. Theranostics (2013) 1.55
Comparison of assay methods for detection of circulating tumor cells in metastatic breast cancer: AdnaGen AdnaTest BreastCancer Select/Detect™ versus Veridex CellSearch™ system. Int J Cancer (2011) 1.38
KI-67 AND hTERT expression can aid in the distinction between malignant and benign pheochromocytoma and paraganglioma. Mod Pathol (2003) 1.36
Cancer Response Criteria and Bone Metastases: RECIST 1.1, MDA and PERCIST. J Cancer (2010) 1.27
Prognostic impact of circulating tumor cells assessed with the CellSearch System™ and AdnaTest Breast™ in metastatic breast cancer patients: the DETECT study. Breast Cancer Res (2012) 1.21
Estrogen and progesterone hormone receptor status in breast carcinoma: comparison of immunocytochemistry and immunohistochemistry. Indian J Cancer (2010) 1.15
Circulating tumor cells in breast cancer. Curr Opin Obstet Gynecol (2008) 1.06
Efficiency of whole genome amplification of single circulating tumor cells enriched by CellSearch and sorted by FACS. Genome Med (2013) 1.05
Vimentin expression appears to be associated with poor prognosis in node-negative ductal NOS breast carcinomas. Am J Pathol (1990) 1.03
Micrometastatic disease in breast cancer: clinical implications. Eur J Cancer (2008) 1.03
Circulating tumor cells in solid tumor in metastatic and localized stages. Anticancer Res (2009) 1.00
The clinical significance of disseminated tumor cells in breast cancer. Nat Clin Pract Oncol (2007) 0.97
Outcomes in young women with breast cancer of triple-negative phenotype: the prognostic significance of CK19 expression. Int J Radiat Oncol Biol Phys (2007) 0.96
Clinical utility of circulating tumor cell counting through CellSearch(®): the dilemma of a concept suspended in Limbo. Onco Targets Ther (2014) 0.86
Circulating and disseminated tumor cells in the clinical management of breast cancer patients: unanswered questions. Oncology (2009) 0.85
HER-2 DNA quantification of paraffin-embedded breast carcinomas with LightCycler real-time PCR in comparison to immunohistochemistry and chromogenic in situ hybridization. Clin Biochem (2006) 0.80
Detection of circulating tumor cells in patients with breast cancer using the quantitative RT-PCR assay for monitoring of therapy efficacy. Exp Mol Pathol (2014) 0.79
TOP2A protein by quantitative immunofluorescence as a predictor of response to epirubicin in the neoadjuvant treatment of breast cancer. Future Oncol (2013) 0.75
Detection of circulating tumor cells in patients with breast cancer using the quantitative RT-PCR assay for monitoring of therapy efficacy. Exp Mol Pathol (2014) 0.79
Diagnostic performance of HPV E6/E7, hTERT, and Ki67 mRNA RT-qPCR assays on formalin-fixed paraffin-embedded cervical tissue specimens from women with cervical cancer. Exp Mol Pathol (2015) 0.78
Prevalence of type-specific oncogenic human papillomavirus infection assessed by HPV E6/E7 mRNA among women with high-grade cervical lesions. Int J Infect Dis (2015) 0.75
Evaluation of a quantitative RT-PCR assay to detect HER2 mRNA overexpression for diagnosis and selection of trastuzumab therapy in breast cancer tissue samples. Exp Mol Pathol (2014) 0.75